Cargando…

The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes

OBJECTIVE: Continuous glucose monitoring (CGM) has been found to improve glucose control in type 1 diabetic patients. We estimated the cost-effectiveness of CGM versus standard glucose monitoring in type 1 diabetes. RESEARCH DESIGN AND METHODS: This societal cost-effectiveness analysis (CEA) was con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Elbert S., O'Grady, Michael, Basu, Anirban, Winn, Aaron, John, Priya, Lee, Joyce, Meltzer, David, Kollman, Craig, Laffel, Lori, Tamborlane, William, Weinzimer, Stuart, Wysocki, Tim
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875436/ https://www.ncbi.nlm.nih.gov/pubmed/20332354 http://dx.doi.org/10.2337/dc09-2042

Ejemplares similares

A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
por: Mauras, Nelly, et al.
Publicado: (2012)

Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
por: Tansey, Michael, et al.
Publicado: (2013)

Projecting the Future Diabetes Population Size and Related Costs for the U.S.
por: Huang, Elbert S., et al.
Publicado: (2009)

International Consensus on Use of Continuous Glucose Monitoring
por: Danne, Thomas, et al.
Publicado: (2017)

Persistence of Individual Variations in Glycated Hemoglobin: Analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial
por: Wilson, Darrell M., et al.
Publicado: (2011)

Early Pharmacokinetic and Pharmacodynamic Effects of Mixing Lispro With Glargine Insulin: Results of glucose clamp studies in youth with type 1 diabetes
por: Cengiz, Eda, et al.
Publicado: (2010)

Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes
por: Weinzimer, Stuart A., et al.
Publicado: (2012)

Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes
por: Buckingham, Bruce, et al.
Publicado: (2013)

Safety of Nighttime 2-Hour Suspension of Basal Insulin in Pump-Treated Type 1 Diabetes Even in the Absence of Low Glucose
por: Sherr, Jennifer L., et al.
Publicado: (2014)

Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes
por: Sherr, Jennifer L., et al.
Publicado: (2013)

Evolution of Abnormal Plasma Glucagon Responses to Mixed-Meal Feedings in Youth With Type 1 Diabetes During the First 2 Years After Diagnosis
por: Sherr, Jennifer, et al.
Publicado: (2014)

Lack of Association Between Residual Insulin Production and Glucagon Response to Hypoglycemia in Youth With Short Duration of Type 1 Diabetes
por: Sherr, Jennifer, et al.
Publicado: (2013)

Accuracy of a Seventh-Generation Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes
por: Laffel, Lori M., et al.
Publicado: (2022)

Depressive Symptoms and Glycemic Control in Adolescents With Type 1 Diabetes: Mediational role of blood glucose monitoring
por: McGrady, Meghan E., et al.
Publicado: (2009)

Response to Comment on: Wilson et al. Persistence of Individual Variations in Glycated Hemoglobin: Analysis of Data From the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial. Diabetes Care 2011;34:1315–1317
por: Wilson, Darrell M., et al.
Publicado: (2011)

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes
por: Laffel, Lori M., et al.
Publicado: (2017)

Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association
por: Chiang, Jane L., et al.
Publicado: (2018)

The Alteration of Aspart Insulin Pharmacodynamics When Mixed With Detemir Insulin
por: Cengiz, Eda, et al.
Publicado: (2012)

Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections
por: Foster, Nicole C., et al.
Publicado: (2016)

Pharmacokinetic and pharmacodynamic profile of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial
por: Laffel, L. M. B., et al.
Publicado: (2018)

Achievement of Target A1C Levels With Negligible Hypoglycemia and Low Glucose Variability in Youth With Short-Term Type 1 Diabetes and Residual β-Cell Function
por: Sherr, Jennifer, et al.
Publicado: (2012)

Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes
por: Hilliard, Marisa E., et al.
Publicado: (2022)

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
por: Battelino, Tadej, et al.
Publicado: (2019)

A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of America
por: Winn, Aaron, et al.
Publicado: (2023)

The Cost-Effectiveness of Personalized Genetic Medicine: The case of genetic testing in neonatal diabetes
por: Greeley, Siri Atma W., et al.
Publicado: (2011)

Dietary Behaviors Predict Glycemic Control in Youth With Type 1 Diabetes
por: Mehta, Sanjeev N., et al.
Publicado: (2008)

Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes
por: Hermanns, Norbert, et al.
Publicado: (2022)

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
por: Garg, Satish K., et al.
Publicado: (2017)

Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
por: Naylor, Rochelle N., et al.
Publicado: (2014)

Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
por: Feig, Denice S, et al.
Publicado: (2017)

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes
por: Bjornstad, Petter, et al.
Publicado: (2018)

An Effective Diabetic Ketoacidosis Prevention Intervention in Children With Type 1 Diabetes
por: Vitale, Rebecca J., et al.
Publicado: (2018)

Diabetes Care for Emerging Adults: Recommendations for Transition From Pediatric to Adult Diabetes Care Systems: A position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society (formerly Lawson Wilkins Pediatric Endocrine Society)
por: Peters, Anne, et al.
Publicado: (2011)

PSUN267 New-Onset Type 1 Diabetes (T1D) In a Child Presenting With Diabetic Ketoacidosis (DKA) and Severe Hypertriglyceridemia Without Pancreatitis
por: Vitale, Rebecca, et al.
Publicado: (2022)

Longitudinal Assessment of Neuroanatomical and Cognitive Differences in Young Children With Type 1 Diabetes: Association With Hyperglycemia
por: Mauras, Nelly, et al.
Publicado: (2015)

Closed-Loop Systems: Diversity and Natural Selection
por: Weinzimer, Stuart A.
Publicado: (2012)

The Use of an Automated, Portable Glucose Control System for Overnight Glucose Control in Adolescents and Young Adults With Type 1 Diabetes
por: O'Grady, Michael J., et al.
Publicado: (2012)

The View From the Cusp of the “Third Act”
por: Porter-O'Grady, Tim
Publicado: (2020)

Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model
por: Hinahara, Jordan, et al.
Publicado: (2022)

Effect of Age of Infusion Site and Type of Rapid-Acting Analog on Pharmacodynamic Parameters of Insulin Boluses in Youth With Type 1 Diabetes Receiving Insulin Pump Therapy
por: Swan, Karena L., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_62im7r7ebocli0gvh2m4jip0rk